Domov › Nemalicelični pljučni rak › Pennsylvania › Reading

Klinične študije za Nemalicelični pljučni rak v Reading, PA

9 študij za Nemalicelični pljučni rak išče udeležence na lokacijah v Reading in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Vključevanje udeležencevFaza 3

Reading Hospital, West Reading · 1 mi stran
Ephrata Cancer Center, Ephrata · 17 mi stran
Sechler Family Cancer Center, Lebanon · 26 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT04267848

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Vključevanje udeležencevFaza 3

Reading Hospital, West Reading · 1 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06498635

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Vključevanje udeležencevFaza 2

McGlinn Cancer Institute Reading Hospital, West Reading · 1 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06667076

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Vključevanje udeležencevFaza 3

Reading Hospital - McGlinn Cancer Institute, West Reading · 1 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT06793215

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Vključevanje udeležencevFaza 2

Ephrata Cancer Center, Ephrata · 17 mi stran
Sechler Family Cancer Center, Lebanon · 26 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 3. jun. 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Vključevanje udeležencevFaza 2

Ephrata Cancer Center, Ephrata · 17 mi stran
Sechler Family Cancer Center, Lebanon · 26 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 6. maj 2026 · NCT06116682

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Vključevanje udeležencevFaza 2

Ephrata Cancer Center, Ephrata · 17 mi stran
Sechler Family Cancer Center, Lebanon · 26 mi stran

18 Minutes · Vsi spoli · Posodobljeno 5. maj 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Vključevanje udeležencevFaza 2/3

Ephrata Cancer Center, Ephrata · 17 mi stran
Sechler Family Cancer Center, Lebanon · 26 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 5. maj 2026 · NCT06616584

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Vključevanje udeležencevOpazovalna študija

Ephrata Cancer Center, Ephrata · 17 mi stran
Sechler Family Cancer Center, Lebanon · 26 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 17. mar. 2026 · NCT06418204

Študije za Nemalicelični pljučni rak v drugih mestih

Druge študije v Reading

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.